[go: up one dir, main page]

MX2008015323A - Composicion farmaceutica que comprende ciclobenzaprina y aceclofenac en asociacion. - Google Patents

Composicion farmaceutica que comprende ciclobenzaprina y aceclofenac en asociacion.

Info

Publication number
MX2008015323A
MX2008015323A MX2008015323A MX2008015323A MX2008015323A MX 2008015323 A MX2008015323 A MX 2008015323A MX 2008015323 A MX2008015323 A MX 2008015323A MX 2008015323 A MX2008015323 A MX 2008015323A MX 2008015323 A MX2008015323 A MX 2008015323A
Authority
MX
Mexico
Prior art keywords
association
aceclofenac
cyclobenzaprine
pharmaceutical composition
treatment
Prior art date
Application number
MX2008015323A
Other languages
English (en)
Inventor
Dante Junior Alario
Julio Cesar Glagliardi
Original Assignee
Incrementha P D & I Pesquisa Desenvolvimento E Inovacao De Farmacos E Medicamentos Ltda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incrementha P D & I Pesquisa Desenvolvimento E Inovacao De Farmacos E Medicamentos Ltda filed Critical Incrementha P D & I Pesquisa Desenvolvimento E Inovacao De Farmacos E Medicamentos Ltda
Publication of MX2008015323A publication Critical patent/MX2008015323A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Asociación de ingredientes activos que se relaciona, más específicamente, con una asociación de ciclobenzaprina y aceclofenac. Adicionalmente, se describe el uso de aceclofenac y ciclobenzaprina en asociación para la preparación de un medicamento útil en el tratamiento de enfermedades musculares dolorosas, y también con un método para el tratamiento de enfermedades musculares dolorosas mediante el uso de una asociación de aceclofenac y ciclobenzaprina.
MX2008015323A 2006-06-08 2007-06-06 Composicion farmaceutica que comprende ciclobenzaprina y aceclofenac en asociacion. MX2008015323A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BRPI0602179-4A BRPI0602179A (pt) 2006-06-08 2006-06-08 composição farmacêutica compreendendo ciclobenzaprina e aceclofenaco em combinação
PCT/BR2007/000139 WO2007140555A1 (en) 2006-06-08 2007-06-06 Pharmaceutical composition comprising cyclobenzaprine and aceclofenac in association

Publications (1)

Publication Number Publication Date
MX2008015323A true MX2008015323A (es) 2009-04-22

Family

ID=38800984

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2008015323A MX2008015323A (es) 2006-06-08 2007-06-06 Composicion farmaceutica que comprende ciclobenzaprina y aceclofenac en asociacion.

Country Status (6)

Country Link
US (1) US8835495B2 (es)
EP (1) EP2034829A4 (es)
JP (1) JP2009539776A (es)
BR (1) BRPI0602179A (es)
MX (1) MX2008015323A (es)
WO (1) WO2007140555A1 (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012137054A1 (en) 2011-04-06 2012-10-11 Campiglio Consulting Srl Pharmaceutical composition containing cyclobenzaprine suitable to intranasal administration

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010133961A1 (en) 2009-05-22 2010-11-25 Inventia Healthcare Private Limited Extended release compositions of cyclobenzaprine
US9346742B2 (en) * 2012-05-10 2016-05-24 Cellix Bio Private Limited Compositions and methods for the treatment of fibromyalgia pain
CN109316457B (zh) * 2018-11-26 2021-07-13 正大制药（青岛）有限公司 一种盐酸环苯扎林缓释制剂及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ191624A (en) * 1978-10-04 1983-09-30 Merck & Co Inc Skeletal muscle relaxant containing cyclobenzaprine and diflunisal
ATE173638T1 (de) * 1993-06-17 1998-12-15 Farco Gmbh Verfahren zur herstellung einer sterilen bereitschaftspackung und behältnis für eine solche bereitschaftspackung
WO1999012524A1 (en) * 1997-09-11 1999-03-18 Nycomed Danmark A/S MODIFIED RELEASE MULTIPLE-UNITS COMPOSITIONS OF NON-STEROID ANTI-INFLAMMATORY DRUG SUBSTANCES (NSAIDs)
US6235311B1 (en) * 1998-03-18 2001-05-22 Bristol-Myers Squibb Company Pharmaceutical composition containing a combination of a statin and aspirin and method
DE19927688A1 (de) * 1999-06-17 2000-12-21 Gruenenthal Gmbh Mehrschichttablette zur Verabreichung einer fixen Kombination von Tramadol und Diclofenac
US20020066691A1 (en) * 2000-12-04 2002-06-06 Varon Steven C. Therapy pack
AU2002337815A1 (en) * 2001-10-05 2003-04-22 Suwalee Chandrkrachang Active agents using liposome beads

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012137054A1 (en) 2011-04-06 2012-10-11 Campiglio Consulting Srl Pharmaceutical composition containing cyclobenzaprine suitable to intranasal administration

Also Published As

Publication number Publication date
US8835495B2 (en) 2014-09-16
JP2009539776A (ja) 2009-11-19
EP2034829A4 (en) 2009-12-02
EP2034829A1 (en) 2009-03-18
US20090306204A1 (en) 2009-12-10
WO2007140555A1 (en) 2007-12-13
BRPI0602179A (pt) 2008-01-22

Similar Documents

Publication Publication Date Title
MX2009002314A (es) Composiciones farmaceuticas que comprenden hgh para suministro oral.
MY143795A (en) Tetrahydropyridoindole derivatives
WO2008027350A3 (en) Acetaminophen pharmaceutical compositions
EA201300121A1 (ru) Ингибитор дпп-4 в комбинации с дополнительным противодиабетическим агентом, таблетки, включающие указанные композиции, их применение и способ их получения
MX2010005631A (es) Nuevos compuestos de hidrocarburo ciclicos para el tratamiento de enfermedades.
MX2010002392A (es) Composiciones de brimonidina mejoradas para tratar eritema.
DE602005021770D1 (de) Indol-1-yl-essigsäurederivate
MX2010009625A (es) Derivados de 1-bencil-3-hidroximetilindazol y uso de los mismos en el tratamiento de enfermedades basadas en la expresion de mcp-1, cx3cr1 y p40.
WO2007012019A3 (en) Medicaments containing famotidine and ibuprofen and administration of same
MX2009009133A (es) Composiciones medicinales mejoradas que comprenden buprenorfina y naloxona.
MX2012000275A (es) Antagonista de bomba de acido para el tratamiento de enfermedades involucradas en la motilidad gastrointestinal anormal.
IL196425A0 (en) Pharmaceutical compositions containing ibuprofen and famotidine
MX2010009624A (es) Derivados de 1-bencil-3-hidroximetilindazol y uso de los mismos en el tratamiento de enfermedades basadas en la expresion de mcp-1 y cx3cr1.
WO2008112773A3 (en) Droxidopa and pharmaceutical composition thereof for the treatment of neurally mediated hypotension
MX2012005689A (es) Analogos de acido araquidonico y metodos para el tratamiento analgesico utilizando los mismos.
GB2456475A (en) Composition for the treatment of skin conditions
TW200719882A (en) Treatment of connective tissue diseases of the skin
WO2009099553A3 (en) Use of kinase inhibitor in treatment of atherosclerosis
UA96794C2 (ru) Глюкокортикоиды, способ их применения, способ лечения и фармацевтическая композиция на их основе
TNSN08506A1 (en) Substituted carboxamides
MX2007004955A (es) Metodo de tratar cancer con formulaciones de compeusto de platino a base de lipido administradas intraperitonealmente.
MX341660B (es) Agonista del receptor de ghrelina para el tratamiento de caquexia.
WO2008051527A3 (en) Sustained release of agents for localized pain management
WO2007018588A8 (en) Stable pharmaceutical composition comprising linezolid form iv
MX2008015323A (es) Composicion farmaceutica que comprende ciclobenzaprina y aceclofenac en asociacion.

Legal Events

Date Code Title Description
FG Grant or registration
HC Change of company name or juridical status

Owner name: EUROFARMA LABORATORIOS LTDA.*

PD Change of proprietorship

Owner name: EUROFARMA LABORATORIOS LTDA.*